These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 25794984

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of sitagliptin on plaque changes in coronary artery following acute coronary syndrome in diabetic patients: The ESPECIAL-ACS study.
    Kuramitsu S, Miyauchi K, Yokoi H, Suwa S, Nishizaki Y, Yokoyama T, Nojiri S, Iwabuchi M, Shirai S, Ando K, Okazaki S, Tamura H, Watada H, Daida H.
    J Cardiol; 2017 Jan; 69(1):369-376. PubMed ID: 27641967
    [Abstract] [Full Text] [Related]

  • 3. Effects of sitagliptin on coronary atherosclerosis in patients with type 2 diabetes-A serial integrated backscatter-intravascular ultrasound study.
    Nozue T, Fukui K, Koyama Y, Fujii H, Kunishima T, Hikita H, Hibi K, Miyazawa A, Michishita I, TRUST InvestigatorsDivision of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital Yokohama, Japan..
    Am J Cardiovasc Dis; 2016 Jan; 6(4):153-162. PubMed ID: 28078175
    [Abstract] [Full Text] [Related]

  • 4. Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes.
    Li B, Luo YR, Tian F, Chen YD, Tian JW, Ding Y, Zhu M, Li JW, Zhang YQ, Shi WM.
    Atherosclerosis; 2020 May; 300():10-18. PubMed ID: 32247073
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design.
    Watanabe T, Miyamoto T, Miyasita T, Shishido T, Arimoto T, Takahashi H, Nishiyama S, Hirono O, Matsui M, Sugawara S, Ikeno E, Miyawaki H, Akira F, Kubota I.
    J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140
    [Abstract] [Full Text] [Related]

  • 6. Effects of alogliptin on fractional flow reserve evaluated by coronary computed tomography angiography in patients with type 2 diabetes: Rationale and design of the TRACT study.
    Nozue T, Fukui K, Takamura T, Sozu T, Hibi K, Kishi S, Michishita I.
    J Cardiol; 2017 Mar; 69(3):518-522. PubMed ID: 27236239
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study.
    Kashiyama K, Sonoda S, Muraoka Y, Suzuki Y, Kamezaki F, Tsuda Y, Araki M, Tamura M, Takeuchi M, Abe H, Okazaki M, Fujino Y, Otsuji Y.
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):935-45. PubMed ID: 25724567
    [Abstract] [Full Text] [Related]

  • 9. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L, Maeng M, Thayssen P, Christiansen EH, Hansen KN, Kaltoft A, Hansen HS, Thuesen L, Lassen JF, Jensen LO.
    Catheter Cardiovasc Interv; 2014 May 01; 83(6):864-72. PubMed ID: 23996918
    [Abstract] [Full Text] [Related]

  • 10. Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial.
    Ueda S, Shimabukuro M, Arasaki O, Node K, Nomiyama T, Morimoto T.
    Cardiovasc Drugs Ther; 2018 Feb 01; 32(1):73-80. PubMed ID: 29435776
    [Abstract] [Full Text] [Related]

  • 11. Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.
    Yamada H, Tanaka A, Kusunose K, Amano R, Matsuhisa M, Daida H, Ito M, Tsutsui H, Nanasato M, Kamiya H, Bando YK, Odawara M, Yoshida H, Murohara T, Sata M, Node K, PROLOGUE Study Investigators.
    Cardiovasc Diabetol; 2017 May 11; 16(1):63. PubMed ID: 28490337
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology (TRUTH Study): rationale and design.
    Nozue T, Yamamoto S, Tohyama S, Umezawa S, Kunishima T, Sato A, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Sozu T, Michishita I, Kanagawa PTCA Conference Study Group.
    Circ J; 2009 Feb 11; 73(2):352-5. PubMed ID: 19110505
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dipeptidyl peptidase-4 inhibitor sitagliptin improves pancreatic β-cell function in hypertensive diabetic patients treated with angiotensin receptor blockers.
    Fukui K, Kawahito H, Wakana N, Kikai M, Terada K, Yamamoto K, Irie D, Kato T, Miyagawa S, Yamada H.
    J Renin Angiotensin Aldosterone Syst; 2015 Dec 11; 16(4):1001-9. PubMed ID: 26195265
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
    Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Murakami M, Hirose E, Sato S, Ohkawa K, Ishizawa M, Yamaji H, Kawamura H, Kusachi S, Murakami T, Hina K, Ohe T.
    J Am Coll Cardiol; 2010 Mar 09; 55(10):976-82. PubMed ID: 20202514
    [Abstract] [Full Text] [Related]

  • 18. Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation.
    Arora S, Ofstad AP, Ulimoen GR, Birkeland KI, Endresen K, Gullestad L, Johansen OE.
    Cardiovasc Diabetol; 2019 Mar 09; 18(1):26. PubMed ID: 30851727
    [Abstract] [Full Text] [Related]

  • 19. Sitagliptin and cardiovascular outcomes in diabetic patients with chronic kidney disease and acute myocardial infarction: A nationwide cohort study.
    Chen DY, Wang SH, Mao CT, Tsai ML, Lin YS, Chou CC, Wen MS, Wang CC, Hsieh IC, Hung KC, Chen TH.
    Int J Cardiol; 2015 Feb 15; 181():200-6. PubMed ID: 25528312
    [Abstract] [Full Text] [Related]

  • 20. DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages.
    Brenner C, Franz WM, Kühlenthal S, Kuschnerus K, Remm F, Gross L, Theiss HD, Landmesser U, Kränkel N.
    Int J Cardiol; 2015 Nov 15; 199():163-9. PubMed ID: 26197403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.